Detection of Cerebral Microbleeds with Quantitative Susceptibility Mapping in the Arcabeta Mouse Model of Cerebral Amyloidosis

Cerebral microbleeds (CMBs) are findings in patients with neurological disorders such as cerebral amyloid angiopathy and Alzheimer's disease, and are indicative of an underlying vascular pathology. A diagnosis of CMBs requires an imaging method that is capable of detecting iron-containing lesions with high sensitivity and spatial accuracy in the presence of potentially confounding tissue abnormalities. In this study, we investigated the feasibility of quantitative magnetic susceptibility mapping (QSM), a novel technique based on gradient-recalled echo (GRE) phase data, for the detection of CMBs in the arcAβ mouse, a mouse model of cerebral amyloidosis. Quantitative susceptibility maps were generated from phase data acquired with a high-resolution T2∗-weighted GRE sequence at 9.4 T. We examined the influence of different regularization parameters on susceptibility computation; a proper adjustment of the regularization parameter minimizes streaking artifacts and preserves fine structures. In the present study, it is shown that QSM provides increased detection sensitivity of CMBs and improved contrast when compared with GRE magnitude imaging. Furthermore, QSM corrects for the blooming effect observed in magnitude and phase images and depicts both the localization and spatial extent of CMBs with high accuracy. Therefore, QSM may become an important tool for diagnosing CMBs in neurological diseases.

[1]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[2]  P. Harrison,et al.  Siderosomal ferritin. The missing link between ferritin and haemosiderin? , 1987, The Biochemical journal.

[3]  J. Connor,et al.  Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease , 1992, Journal of neuroscience research.

[4]  J. Schenck,et al.  Health and Physiological Effects of Human Exposure to Whole‐Body Four‐Tesla Magnetic Fields during MRI , 1992, Annals of the New York Academy of Sciences.

[5]  J. Schenck.  The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. , 1996, Medical physics.

[6]  R. Quester,et al.  The shrinkage of the human brain stem during formalin fixation and embedding in paraffin , 1997, Journal of Neuroscience Methods.

[7]  J R Reichenbach,et al.  Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. , 1997, Radiology.

[8]  L R Schad,et al.  High-resolution MR venography of cerebral arteriovenous malformations. , 1999, Magnetic resonance imaging.

[9]  C. Rorden,et al.  Stereotaxic display of brain lesions. , 2000, Behavioural neurology.

[10]  J R Reichenbach,et al.  High-Resolution MR Venography at 3.0 Tesla , 2000, Journal of computer assisted tomography.

[11]  L R Schad,et al.  Improved target volume characterization in stereotactic treatment planning of brain lesions by using high‐resolution BOLD MR‐venography , 2001, NMR in biomedicine.

[12]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[13]  E. Haacke,et al.  High‐resolution BOLD venographic imaging: a window into brain function , 2001, NMR in biomedicine.

[14]  Markus Barth,et al.  High-Resolution Three-Dimensional Contrast-Enhanced Blood Oxygenation Level-Dependent Magnetic Resonance Venography of Brain Tumors at 3 Tesla: First Clinical Experience and Comparison with 1.5 Tesla , 2003, Investigative radiology.

[15]  J. Oosterhuis,et al.  Cervical tissue shrinkage by formaldehyde fixation, paraffin wax embedding, section cutting and mounting , 2004, Virchows Archiv A.

[16]  Khadija Iqbal,et al.  Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia , 2004, Acta Neuropathologica.

[17]  J. Reichenbach,et al.  Magnetic susceptibility-weighted MR phase imaging of the human brain. , 2005, AJNR. American journal of neuroradiology.

[18]  Jeff H. Duyn,et al.  High-field MRI of brain cortical substructure based on signal phase , 2007, Proceedings of the National Academy of Sciences.

[19]  Roger M. Nitsch,et al.  Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice , 2007, Neurobiology of Aging.

[20]  Francis Lilley,et al.  Fast and robust three-dimensional best path phase unwrapping algorithm. , 2007, Applied optics.

[21]  K. Jellinger,et al.  Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage , 2007, European journal of neurology.

[22]  R. Nitsch,et al.  Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. , 2007, Neurobiology of aging.

[23]  Gregory M. Szilagyi,et al.  Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. , 2008, Archives of neurology.

[24]  Jan Sedlacik,et al.  Susceptibility weighted imaging at ultra high magnetic field strengths: Theoretical considerations and experimental results , 2008, Magnetic resonance in medicine.

[25]  Steven Warach,et al.  Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .

[26]  Eric E. Smith,et al.  MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength , 2008, American Journal of Neuroradiology.

[27]  Lisa M. Miller,et al.  Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease , 2009, NeuroImage.

[28]  Andreas Schäfer,et al.  Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI , 2009, NeuroImage.

[29]  E. Mark Haacke,et al.  Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study , 2010, Acta Neuropathologica.

[30]  J. Duyn,et al.  Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data , 2009, Magnetic resonance in medicine.

[31]  Rolf Gruetter,et al.  On the origin of the MR image phase contrast: An in vivo MR microscopy study of the rat brain at 14.1 T , 2009, NeuroImage.

[32]  E Mark Haacke,et al.  Imaging cerebral microbleeds using susceptibility weighted imaging: One step toward detecting vascular dementia , 2010, Journal of magnetic resonance imaging : JMRI.

[33]  Richard Bowtell,et al.  Whole-brain susceptibility mapping at high field: A comparison of multiple- and single-orientation methods , 2010, NeuroImage.

[34]  J. Reichenbach,et al.  Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. , 2010, Medical physics.

[35]  Yi Wang,et al.  Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging , 2010, Magnetic resonance in medicine.

[36]  Yi Wang,et al.  A novel background field removal method for MRI using projection onto dipole fields (PDF) , 2011, NMR in biomedicine.

[37]  Ferdinand Schweser,et al.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.

[38]  Wiesje M van der Flier,et al.  Brain microbleeds and Alzheimer's disease: innocent observation or key player? , 2011, Brain : a journal of neurology.

[39]  Stefan Vogt,et al.  Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease , 2011, NeuroImage.